BOSTON, Aug. 20 /PRNewswire-USNewswire/ -- In one of only two studies of its kind, a study from researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts demonstrates that non-viral gene therapy can delay the onset of some forms of eye disease and preserve vision.
Researchers Use Nanoparticles as Destructive Beacons to Zap Tumors
PHILADELPHIA, July 21 /PRNewswire-USNewswire/ -- A group of researchers from Wake Forest University Baptist Medical Center is developing a way to treat cancer by using lasers to light up tiny nanoparticles and destroy tumors with the ensuing heat.
Frost & Sullivan Recognizes Vive Nano for Innovation in Nanomaterial Encapsulation Technology
MOUNTAIN VIEW, Calif., June 21 /PRNewswire/ -- Based on its recent analysis of the nanomaterial encapsulation technology market, Frost & Sullivan recognizes Vive Nano with the 2010 North American Frost & Sullivan Award for Technology Innovation for a unique encapsulation technology to synthesize nanoparticles.
